Myocarditis clinical trials
12 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- MYTHS - MYocarditis THerapy With Steroids
- Abatacept in Immune Checkpoint Inhibitor Myocarditis
- Hydrogen's Feasibility and Safety as a Therapy in ECPR
- Quantitative Cardiac Parametric Mapping
- Cell Free DNA in Cardiac Sarcoidosis
- Role of Novel ILR in the Management of PVCs
- Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- Mayo AVC Registry and Biobank
- MCE Molecular Imaging for ICI Myocarditis
- Myocarditis Causing Premature Ventricular Contractions:Insights From the MAVERIC Registry
- The ORCHESTRATE-Myocarditis Registry
- A Study to Learn About The COVID-19 (Study) Vaccine (Called COMIRNATY) in People That Are Less Than 21 Years Old.
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Myocarditis” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.